New article on sex differences in Arrhythmogenic Cardiomyopathy! Higher arrhythmic risk in males was confounded by exercise habits. No sex differences in disease progression after exercise restriction. Open access: academic.oup.com/europace/advan…

Females with arrhythmogenic cardiomyopathy seem to have equally high risk of life-threatening events as males. An important finding in regards to risk stratification!

Honored and happy for this great achievement - EuroEcho Young Investigator Award 2021. Thank you European Society of Cardiology for an excellent congress. And a big thanks to Kristina Haugaa and Øyvind H Lie for their great guidance and support every step of the way.#euroecho ProCardioSFI

Important work and one step towards understanding exercise induced ARVC ProCardioSFI Christine Rootwelt-Norberg European Society of Cardiology European Society of Cardiology Journals

Our paper was published in EHJ European Society of Cardiology Journals simultaneously with our presentation. European Society of Cardiology ProCardioSFI Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy academic.oup.com/eurheartj/adva…

In patients with cardiac laminopathies, disease progression rate by ECG and echo is an important predictor of future life-threatening arrhythmias. Happy to get this out! Thanks Kristina Haugaa and Øyvind H Lie for excellent supervision and guidance, as always. ProCardioSFI

So happy and proud for how this PhD-defence turned out😁🎓 Forever grateful for supervisors Kristina Haugaa and Øyvind H Lie, all of ProCardioSFI, Thor Edvardsen and the rest of the Department of Cardiology Rikshospitalet and UiO - Det medisinske fakultet

Flecainide may help symptoms in AMVP. More to come…ProCardioSFI @eivindaabel Christine Rootwelt-Norberg Isotta Castrini European Society of Cardiology EHRAPresident HeartRhythm Flecainide in patients with arrhythmic mitral valve syndrome - a case series. pubmed.ncbi.nlm.nih.gov/36566890/

Disease progression rate is a strong predictor of ventricular arrhythmias in pts w/ cardiac laminopathies. Discover more 👉 academic.oup.com/europace/advan… Europace Editor-in-Chief Giulio Conte Dominik Linz @FraSantoroMd Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Marco Vitolo Ⓜ️ Kristina Haugaa @norbergRootwelt #genetics

Flecainide in patients with arrhythmic mitral valve syndrome reduces PVCs and nsVTs heartrhythmjournal.com/article/S1547-…

Timing of ICD implantation in patients with cardiac laminopathies - external validation of the LMNA-risk VTA calculator. Christine Rootwelt-Norberg Kristina Haugaa Øyvind H Lie OPEN ACCESS! heartrhythmjournal.com/article/S1547-…